Robert Barry - President
30 years of technical, clinical, and business experience in the medical device field. Robert has co-founded medical device companies: Coaptus Medical, Stasys Medical, and Uptake Medical. As CEO, he has successfully raised venture capital, developed product, conducted randomized clinical trials, and launched product. Prior to his CEO experience, Robert worked for Boston Scientific, Pfizer, and Bausch & Lomb where he held various engineering and management positions. He has over 25 issued patents in the fields of interventional cardiology, radiology, and pulmonology.
Erik Henne - Vice President of Research and Development
Erik has been leading research and development for vapor technology for the lung since the first pre-clinical study 10 years ago. His major accomplishments include development of the lung ablation dosing algorithm and treatment plan, training of physicians world-wide on the use of lung ablation, and the development of the lung cancer technology from concept to clinical evaluation. In addition to leading the Uptake's research and development efforts, Erik directs the clinical operations team that analyzes lung CT scans to create a personalized treatment plan for all InterVapor patients. He has been awarded 10 patents to date and numerous peer-reviewed publications in medical literature as lead author.
Kristi Jordan - Vice President of Regulatory and Quality
Kristi has spent over 20 years in the medical device industry, primarily in the fields of cardiology and pulmonology. She is experienced in FDA and ISO compliant quality systems, regulatory affairs, supplier quality, product development and project management. Previous companies include Stasys Medical, Uptake Medical Corp, Spiration, Boston Scientific NW, Rosetta Informatics, and Heart Technology.
Todd Cornell – Vice President of Marketing and Sales
Todd has over 23 years of experience in medical device industry. He has held numerous sales and marketing positions at Abbott Vascular, Boston Scientific Corporation and United States Surgical Corporation. The last 14 years of Todd’s career have been spent working in the Pulmonary space with start-up companies focused on the development and commercialization of a non-invasive treatment for emphysema. In this time, Todd has set up a global sales channel for the commercialization of this technology, focused on developing a referral network for the treatment of the disease, assisted in the execution and completion of numerous clinical studies and hired and managed a direct sales force in 8 countries.